• Chinese
Cover Image

2014 Strategies for the French Microbiology Testing Market

Complete report $6,700.  DataPack (test volumes, sales forecasts, supplier shares) $4,300.

2014 Strategies for the French Microbiology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.  The report examines key French market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
 
Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.  

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.  Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation,
  reagents kits, IT and other products with significant market
  appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

- Sales and market shares of major suppliers
  by individual test.

- Volume and sales forecasts for over 100 infectious disease
   assays by individual test and market segment:

     ° Hospitals
     ° Blood Banks
     ° Commercial/Private Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics,
   culture/microscopy).

- Review of the market dynamics, trends,
  structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of over 100 major diseases,
  including their etiology, current diagnostic tests,
  vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
  testing, including their operating
  characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,
  immunoassay, and other technologies and their potential
  applications for infectious disease testing.

- Global listings of companies developing or
  marketing infectious disease diagnostic products
  by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
  emerging market entrants, including their sales, product
  portfolios, marketing tactics, collaborative
  arrangements and new products in R&D.

Contains 890 pages and 160 tables
 

Table of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests

  • 1. AIDS
  • a. Background
  • b. Diagnostic Tests
  • c. Vaccines and Drugs
  • 2. Adenovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
    • d. Adeno-Associated Viruses(AAV)
  • 3. Aeromonas
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 4. Anthrax/Bacillus Anthracis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 5. Arboviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 6. Babesiosis
    • a. Background
  • 7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 8. Blastocystis Hominis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 9. Brucella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 10. Campylobacter
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 11. Candida
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 12. Chagas Disease
    • a. Background
  • 13. Chancroid
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 14. Chlamydia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 15. Clostridium Difficile
    • a. Background
    • b. Diagnostic Tests
    • c. Drugs and Vaccines
  • 16. Coronaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 17. Coxsackieviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 18. Creutzfeldt-Jakob's Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccine
  • 19. Cryptosporidium Parvum
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 20. Cyclospora Cayetanensis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 21. Cytomegalovirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 22. Ebola Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 23. E. Coli
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 24. EchoVirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 25. Encephalitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 26. Enteroviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 27. Epstein-Barr Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 28. Giardia Lamblia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 29. Gonorrhea
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 30. Granuloma Inguinale
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 31. Hantavirus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 32. Helicobacter Pylori
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 33. Hepatitis
    • a. Background
    • b. Hepatitis A
    • c. Hepatitis B
    • d. Hepatitis C
    • e. Vaccines and Drugs
  • 34. Herpes Simplex Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 35. Human Herpes Virus-6 (HHV-6)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 36. Influenza Viruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 37. Legionella
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 38. Lyme Disease
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 39. Lymphogranuloma Venereum (LGV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 40. Malaria
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 41. Measles (Rubeola)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 42. Meningitis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 43. Microsporidium
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 44. Mononucleosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 45. Mumps
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 46. Mycoplasma
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 47. Papillomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 48. Parvovirus B19
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 49. Pneumonia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 50. Polyomaviruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 51. Pseudomonas Aeruginosa
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 52. Rabies
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 53. Respiratory Syncytial Virus (RSV)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 54. RhinoViruses
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 55. RotaVirus (REOVIRUS)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 56. Rubella(MEASLES)
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 57. Salmonellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 58. Septicemia
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 59. Shigellosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 60. Staphylococcus Aureus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 61. Streptococci
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 62. Syphilis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 63. Toxoplasmosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 64. Trichomonas Vaginalis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 65. Tuberculosis
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 66. Vibrio
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 67. West Nile Virus
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs
  • 68. Yersina
    • a. Background
    • b. Diagnostic Tests
    • c. Vaccines and Drugs

B. Instrumentation Review of Leading Analyzers Marketedby Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers

C. Emerging Diagnostic Technologies

  • 1. Molecular Diagnostics
  • 2. Monoclonal Antibodies
  • 3. Immunoassays
  • 4. Differential Light Scattering
  • 5. Information Technology
  • 6. Artificial Intelligence
  • 7. Liposomes
  • 8. Flow Cytometry
  • 9. Chromatography
  • 10. Diagnostic Imaging
  • 11. Gel Microdroplets
  • 12. Other

France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/Panels
  • C. Computers, Software and Automation
  • D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac
  • Wako

List of Tables

  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
  • France Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Laboratories Performing Infectious Disease Tests by Market Segment
  • France Hospital Laboratories Performing Infectious Disease Tests by Bed Size
  • France Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
  • France All Market Segments Infectious Disease Test Volume Forecast
  • France Hospital Laboratories Infectious Disease Test Volume Forecast
  • France Blood Banks Infectious Disease Test Volume Forecast
  • France Commercial/Private Laboratories Infectious Disease Test Volume Forecast
  • France All Market Segments Infectious Disease Diagnostics Market Forecast
  • France Hospital Laboratories Infectious Disease Diagnostics Market Forecast
  • France Blood Banks Infectious Disease Diagnostics Market Forecast
  • France Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
  • France HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HIV Ag Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
  • France BEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Candida Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Coxsackievirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • France CMV Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
  • France E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France EBV Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HBsAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
  • France ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • France HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Measles Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Polyoma Viruses Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
  • France RSV Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
  • France Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France AIDS Testing Market Diagnostics Sales by Major Supplier
  • France Adenovirus Testing Market Diagnostics Sales by Major Supplier
  • France Campylobacter Testing Market Diagnostics Sales by Major Supplier
  • France Candida Testing Market Diagnostics Sales by Major Supplier
  • France Chlamydia Testing Market Diagnostics Sales by Major Supplier
  • France CMV Testing Market Diagnostics Sales by Major Supplier
  • France Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • France Hepatitis Testing Market Diagnostics Sales by Major Supplier
  • France Hepatitis C Testing Market Diagnostics Sales by Major Supplier
  • France Herpes Testing Market Diagnostics Sales by Major Supplier
  • France Lyme Disease Testing Market Diagnostics Sales by Major Supplier
  • France Influenza Testing Market Diagnostics Sales by Major Supplier
  • France Meningitis Testing Market Diagnostics Sales by Major Supplier
  • France Mononucleosis Testing Market Diagnostics Sales by Major Supplier
  • France Mumps Testing Market Diagnostics Sales by Major Supplier
  • France Mycoplasma Testing Market Diagnostics Sales by Major Supplier
  • France RSV Testing Market Diagnostics Sales by Major Supplier
  • France Rotavirus Testing Market Diagnostics Sales by Major Supplier
  • France Rubella Testing Market Diagnostics Sales by Major Supplier
  • France Septicemia Testing Market Diagnostics Sales by Major Supplier
  • France Shigella Testing Market Diagnostics Sales by Major Supplier
  • France Streptococci Testing Market Diagnostics Sales by Major Supplier
  • France Syphilis Testing Market Diagnostics Sales by Major Supplier
  • France Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
  • France Trichomonas Testing Market Diagnostics Sales by Major Supplier
  • France Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Show More
Pricing
Get Notified
Email me when related reports are published